Skip to main content Skip to section navigation Skip to footer
Maravai LifeSciences
  • Contact
  • About
    • About Maravai
    • Leadership
    • Board of Directors
    • Innovation
    • Supply Chain
    • Operations
    • Our People
  • Brands
    • Our Brands
    • TriLink BioTechnologies
    • Cygnus Technologies
    • Glen Research
    • Alphazyme
  • Impact
    • Our Impact
    • Maravai Foundation
  • Insights
    • Our Insights
    • Latest news
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • SEC Filings
    • Sustainability
    • Governance
  • Careers
    • Be a #MiracleMaker
    • Current Openings
    • Benefits and Growth
    • Culture and People

Press releases

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
    • R&D Day 2023
  • Company Info
    • Company Profile
    • Leadership
    • Annual Reports & Proxy
    • Contacts
    • FAQ
    • Analyst Coverage
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Sustainability
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Whistleblower Policy
  • News & Events

  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
  • R&D Day 2023
Jan 28, 2022 8:00 AM EST

Maravai LifeSciences Acquires MyChem, a Leader in Proprietary Ultra-Pure Nucleotides

Jan 25, 2022 5:05 PM EST

Maravai LifeSciences Announces Upcoming Investor Events

Jan 20, 2022 4:05 PM EST

Maravai LifeSciences Announces Debt Repricing

Jan 5, 2022 8:00 AM EST

Maravai LifeSciences Announces Registration and Webcast Information for Upcoming R&D Day, to be Held on January 28, 2022

Dec 14, 2021 8:30 AM EST

Maravai LifeSciences Added to the Nasdaq Biotechnology Index

Dec 9, 2021 4:00 PM EST

Maravai LifeSciences Announces Establishment of New Charitable Foundation

Nov 10, 2021 4:05 PM EST

Maravai LifeSciences Reports Third Quarter Financial Results, Updates 2021 Financial Guidance and Provides Preliminary Revenue Guidance For 2022

Nov 2, 2021 8:30 AM EDT

Maravai LifeSciences Announces November 2021 Investor Conference Schedule

Oct 13, 2021 4:30 PM EDT

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 10, 2021

Oct 7, 2021 5:30 AM EDT

Maravai LifeSciences Expands its Intellectual Property Portfolio with European Patent

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Company Profile
  • Contacts
  • RSS News Feed
Maravai LifeSciences and its brands are the proven catalysts for helping deliver novel vaccines, therapeutics and diagnostics with biotech, biopharma and life sciences companies across the globe.

Extraordinary science.
Everyday miracles.

  • About
    • Leadership
    • Board of Directors
    • Innovation
    • Supply chain
    • Operations
    • Diversity, equity, and inclusion
  • Brands
    • TriLink BioTechnologies
    • Cygnus Technologies
    • Glen Research
    • Alphazyme
  • Helpful links
    • Investors
    • Insights
    • Be a #MiracleMaker
    • Current openings

Connect with us

  • LinkedIn
  • Terms
  • Privacy notice
  • Site map
© 2025 Maravai LifeSciences. All rights reserved